-
Global ALS market may grow to $1.04 bn in 2029 driven by anticipated drug launches
expresspharma
October 09, 2020
A GlobalData report also informs that there are major unmet needs in the ALS market, such as finding curative drugs, receiving earlier diagnosis, identifying reliable biomarkers and extending patient survival.
-
KSRPO asks government to bring in centralised drug enforcement department
expresspharma
September 23, 2020
Highlights need for uniformity in designations and functioning mechanisms of all state FDAs.
-
Viva Biotech and SYNthesis Enters a Strategic Acquisition Agreement, Accelerating the Development of Global Innovative Drug R & D Service Capabilities
prnasia
September 21, 2020
Viva Biotech (Shanghai) Co., Ltd. entered into the Share Purchase Agreement pursuant to which Viva Biotech agreed to acquire and the Vendors agreed to collectively sell 100% of the equity interest in SYNthesis med chem (Hong Kong, S.A.R., China) Limited .
-
Scientists find new drug that may be able to prevent or mitigate severe COVID-19 infection
expresspharma
September 21, 2020
Repurposing the 4-PBA anti-stress drug could modulate such cellular stress and curb mortality caused by respiratory failure derived from cellular stress, said researchers.
-
APIIC signs MoU with CSIR-IICT to establish a bulk drug park
expresspharma
September 04, 2020
CSIR-IICT will be the knowledge partner and offer technical support for the proposal to be submitted to the DoP.
-
Only drug inspectors can probe, file FIRs for certain cognizable offences under D&C Act 1940: SC
expresspharma
September 01, 2020
The Supreme Court recently ruled that drug inspectors can carry out an investigation and file a first information report (FIR) related to cognizable offences which is specified as under the chapter IV of the Drug and Cosmetics Act 1940.
-
Observational study identifies drug that improves survival in sickest COVID-19 patients
worldpharmanews
August 20, 2020
Researchers at Hackensack Meridian Health, New Jersey's largest and most comprehensive health network, have utilized its statewide observational database of more than 5,000 hospitalized COVID-19 patients to show that a drug normally used in rheumatoid ...
-
Scientists identify hundreds of drug candidates to treat COVID-19
worldpharmanews
August 13, 2020
Scientists at the University of California, Riverside, have used machine learning to identify hundreds of new potential drugs that could help treat COVID-19, the disease caused by the novel coronavirus, or SARS-CoV-2.
-
US President orders government to buy drugs from domestic firms
pharmaceutical-technology
August 10, 2020
US President Donald Trump has signed an executive order that requires the federal government to purchase some essential medicines from domestic manufacturers.
-
NICE updates guidance on chronic pain treatments
pharmatimes
August 07, 2020
The UK’s National Institute for Health and Care Excellence (NICE) has published draft guidance which details how some commonly used drug treatments for chronic primary pain have little to no effect.